☰ Chemistry Tree

Qihong Huang, Ph.D.

Affiliations:			The Wistar Institute, USA
	2000		University of California, Davis, Davis, CA

Area:

Pesticide Biotechnology

Google:

Mean distance: 9.65

S

N

B

C

P

Tree Publications Similar researchers PubMed Report error

Parents

Bruce D. Hammock	grad student	2000	UC Davis
(Cloning and characterization of insect genes involved in programmed cell death.)
Peter G. Schultz	post-doc	2001-2005	Scripps Research Institute

Children

Tao Chen	research scientist		The Wistar Institute
Kiranmai Gumireddy	research scientist		The Wistar Institute
Guanghua Huang	research scientist		The Wistar Institute
Anping Li	research scientist		The Wistar Institute
Dong Yang	research scientist		The Wistar Institute

Collaborators

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Yang D, Chen T, Zhan M, et al. (2021) Modulation of mTOR and epigenetic pathways as therapeutics in gallbladder cancer. Molecular Therapy Oncolytics. 20: 59-70
Xiao H, Zeng J, Li H, et al. (2019) Correction: MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis. Oncotarget. 10: 7183-7184
Yang L, Zhang Y, Shan W, et al. (2017) Repression of BET activity sensitizes homologous recombination-proficient cancers to PARP inhibition. Science Translational Medicine. 9
Yang D, Zhan M, Chen T, et al. (2017) miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer. Scientific Reports. 7: 43109
Chen K, Xiao H, Zeng J, et al. (2016) Alternative splicing of EZH2 pre-mRNA by SF3B3 contributes to the tumorigenic potential of renal cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
He Y, Zhu Q, Chen M, et al. (2016) The changing 50% inhibitory concentration (IC50) of cisplatin: a pilot study on the artifacts of the MTT assay and the precise measurement of density-dependent chemoresistance in ovarian cancer. Oncotarget
Zhong X, Zheng L, Shen J, et al. (2016) Suppression of mir-200 family expression by oncogenic KRAS activation promotes cell survival and epithelial-mesenchymal transition in KRAS-driven cancer. Molecular and Cellular Biology
Perales-Puchalt A, Svoronos N, Rutkowski MR, et al. (2016) FOLLICLE-STIMULATING HORMONE RECEPTOR IS EXPRESSED BY MOST OVARIAN CANCER SUBTYPES AND IS A SAFE AND EFFECTIVE IMMUNOTHERAPEUTIC TARGET. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Wang W, Zhan M, Li Q, et al. (2016) FXR agonists enhance the sensitivity of biliary tract cancer cells to cisplatin via SHP dependent inhibition of Bcl-xL expression. Oncotarget
Zhang Y, He Q, Hu Z, et al. (2016) Long noncoding RNA LINP1 regulates repair of DNA double-strand breaks in triple-negative breast cancer. Nature Structural & Molecular Biology

See more...